rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Mary Tagliaferri

Director

Company insider

Files Form 4 as: Director, Iambic Therapeutics; Director, Y-mAbs Therapeutics; Director, RayzeBio; Director, Enzo Biochem; VP, CRO, Treasurer, Secretary, Bionovo.

Every Form 4 they filed

In numbers

Trades disclosed
30
Buys
1
Sells
3
Bought
$9,520
Sold
$409K
Companies
5
Companies where not an officer
4
First trade
26 Jan 2006
Last trade
14 Oct 2026
Last filed
16 Oct 2026

Companies traded

Where they are an officer
BionovoDirector, Officer, 10% owner · last 10 May 20111 buy · 3 sells
Everywhere else they filed: board seats, 10% stakes, other companies
IAM Iambic TherapeuticsDirector · last 14 Oct 20260 buys · 0 sells
Y-mAbs TherapeuticsDirector · last 11 Jun 20240 buys · 0 sells
RayzeBioDirector · last 26 Feb 20240 buys · 0 sells
Enzo BiochemDirector · last 31 Jan 20240 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
14 Oct 2026filed 16 Oct 2026IAM Iambic Therapeuticsoption or derivativeSEC FORM 4 Code A—20,300 at $0.00filing
11 Jun 2024filed 13 Jun 2024Y-mAbs Therapeuticsoption or derivativeSEC FORM 4 Code A—14,545 at $0.00filing
11 Jun 2024filed 13 Jun 2024Y-mAbs TherapeuticsSEC FORM 4 Code A—3,495 at $0.00filing
12 Mar 2024filed 14 Mar 2024Y-mAbs Therapeuticsoption or derivativeSEC FORM 4 Code A—27,900 at $0.00filing
12 Mar 2024filed 14 Mar 2024Y-mAbs TherapeuticsSEC FORM 4 Code A—4,660 at $0.00filing
26 Feb 2024filed 27 Feb 2024RayzeBiooption or derivativeSEC FORM 4 Code D—73,731filing
26 Feb 2024filed 27 Feb 2024RayzeBiooption or derivativeSEC FORM 4 Code D—40,848filing
31 Jan 2024filed 2 Feb 2024Enzo BiochemSEC FORM 4 Code A—79,365 at $0.00filing
9 Feb 2023filed 13 Feb 2023Enzo BiochemSEC FORM 4 Code A—75,188 at $0.00filing
12 Jul 2022filed 14 Jul 2022Enzo BiochemSEC FORM 4 Code A—41,666 at $0.00filing
27 Apr 2022filed 29 Apr 2022Enzo BiochemSEC FORM 4 Code A—39,063 at $0.00filing
11 Jan 2021filed 13 Jan 2021Enzo Biochemoption or derivativeSEC FORM 4 Code A—77,101 at $0.00filing
10 May 2011filed 12 May 2011Bionovooption or derivativeSEC FORM 4 Code A—1,500,000 at $0.00filing
23 Feb 2010filed 23 Feb 2010BionovoSEC FORM 4 Bought$9,52017,000 at $0.56filing
12 Jan 2010filed 14 Jan 2010Bionovooption or derivativeSEC FORM 4 Code A—32,787 at $0.00filing
9 Jul 2009filed 14 Jul 2009BionovoSEC FORM 4 Code J—3,700 at $0.00filing
9 Jul 2009filed 14 Jul 2009BionovoSEC FORM 4 Code J—3,700 at $0.00filing
12 Jun 2009filed 16 Jun 2009BionovoSEC FORM 4 Code G—25,000 at $0.00filing
2 Jun 2009filed 16 Jun 2009BionovoSEC FORM 4 Sold$4,50010,000 at $0.45filing
2 Jun 2009filed 3 Jun 2009BionovoSEC FORM 4 Sold$4,50010,000 at $0.45filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Not placed4

Buys in green, sells in red, by the company’s sector.

Related people

Nobody else traded the same names lately.